ArticleThe American journal of case reports2026
Management of Bilateral Humeral Head Avascular Necrosis in Sickle Cell Disease Using Surgical Intervention With Adjuvant Hyperbaric Oxygen Therapy: A Case Report.
Article in The American journal of case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Avascular necrosis (AVN) is a disabling musculoskeletal complication of sickle cell disease (SCD), resulting from recurrent vaso-occlusive episodes and chronic microvascular ischemia. Although weight-bearing joints such as the femoral head are most commonly affected, humeral head involvement can lead to significant pain and functional limitation. Management of AVN in SCD remains challenging, and interest has grown in adjunctive therapies such as hyperbaric oxygen therapy (HBOT), which can enhance tissue oxygenation, promote angiogenesis, and support bone remodeling. Evidence regarding its role in non-weight-bearing joints remains limited. CASE REPORT A 32-year-old woman with homozygous SCD (HbSS) presented with a 2-month history of progressive bilateral shoulder pain and restricted motion. Magnetic resonance imaging (MRI) demonstrated stage II pre-collapse AVN of both humeral heads. Baseline laboratory evaluation showed stable chronic anemia consistent with SCD, without evidence of acute infection or inflammatory elevation. Following perioperative exchange transfusion to reduce hemoglobin S concentration, she underwent arthroscopic-assisted core decompression with ipsilateral fibular strut autografting of both shoulders in staged procedures. Postoperatively, she completed 40 sessions of HBOT at 2.5 atmospheres absolute for 60 min each, in addition to oral alendronate 70 mg weekly for 6 months. During clinical follow-up, she reported complete resolution of pain and restoration of full, pain-free range of motion bilaterally. Post-treatment MRI demonstrated preserved articular architecture with improvement in marrow signal. CONCLUSIONS This case report shows that a multimodal joint-preserving approach combining surgical decompression and adjunctive HBOT can be associated with meaningful clinical improvement in early-stage humeral head AVN secondary to SCD. However, as multiple concurrent interventions were employed, the independent contribution of HBOT cannot be determined. Larger studies are required to clarify its adjunctive role.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.